RWRobert L. Wan

Robert L. Wan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert L. Wan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Associations of whole-blood fatty acids and dietary intakes with prostate cancer in Jamaica

    by Maria D. Jackson, Susan P. Walker, Candace M. Simpson-Smith, Carole M. Lindsay, Garret Smith, Norma McFarlane-Anderson, Franklyn I. Bennett, Kathleen C. M. Coard, William D. Aiken, Trevor Tulloch, et al.

    To investigate the association of whole-blood fatty acids and reported intakes of fats with risk of prostate cancer (PCa). Case–control study of 209 men 40–80 years old with newly diagnosed, histologically confirmed prostate cancer and 226 cancer-free men attending the same urology clinics. Whole-blood fatty acid composition (mol%) was measured by gas chromatography and diet assessed by food frequency questionnaire. High whole-blood oleic acid composition (tertile 3 vs. tertile 1: OR, 0.37; CI, 0.14–0.0.98) and moderate palmitic acid proportions (tertile 2: OR, 0.29; CI, 0.12–0.70) (tertile 3: OR, 0.53; CI, 0.19–1.54) were inversely related to risk of PCa, whereas men with high linolenic acid proportions were at increased likelihood of PCa (tertile 3 vs. tertile 1: OR, 2.06; 1.29–3.27). Blood myristic, stearic and palmitoleic acids were not associated with PCa. Higher intakes of dietary MUFA were inversely related to prostate cancer (tertile 3 vs. tertile 1: OR, 0.39; CI 0.16–0.92). The principal source of dietary MUFA was avocado intake. Dietary intakes of other fats were not associated with PCa. Whole-blood and dietary MUFA reduced the risk of prostate cancer. The association may be related to avocado intakes. High blood linolenic acid was directly related to prostate cancer. These associations warrant further investigation.


  • Body size and risk of prostate cancer in Jamaican men

    by Maria D. Jackson, Susan P. Walker, Candace M. Simpson, Norma McFarlane-Anderson, Franklyn I. Bennett, Kathleen C. M. Coard, William D. Aiken, Trevor Tulloch, Tomlin J. Paul, Robert L. Wan

    We investigated the associations between body size and risk of prostate cancer in a hospital-based case–control study in Jamaica. Height, weight, waist, and hip circumference were measured at enrollment, and data collected on medical and lifestyle factors for newly diagnosed cases (n = 243) and controls (n = 275). Compared with men in the normal range of waist-hip ratio (WHR), men with WHR ≥0.95 were at greater risk of total prostate cancer (OR,1.72; CI, 1.01–3.00) and high-grade cancer (OR, 2.02; CI, 1.03–3.96). With additional control for BMI, the association with WHR remained significant for total prostate cancer (OR, 1.90; CI, 1.01–3.53) and high-grade disease (OR, 2.94; CI, 1.34–6.38). There was no association between waist circumference and cancer without control for BMI but after controlling for BMI, waist circumference >90 cm (OR, 2.45; CI, 1.01–5.94) and >102 cm (OR, 5.57; CI, 1.43–18.63) showed a dose–response relationship with high-grade disease. Height and BMI were not associated with risk of prostate cancer. Abdominal obesity may be associated with risk of high-grade prostate cancer. Risk may be greater in those with higher abdominal obesity relative to overall size. The results further highlight the importance of investigating relationships by characteristics of the tumor.